Silva Markovic‐Plese

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.

J Zhang, Silva Markovic‐Plese, B Lacet et al. · The Journal of Experimental Medicine · 1994 · 532 citations · Full text

Clinical Immunology, Myelin-reactive T Cells, T-regulatory Cell +19

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

Timothy R. Vollmer, Lyndon Key, Valerie Durkalski et al. · The Lancet · 2004 · 469 citations

Oral Simvastatin Treatment, Neurological Disorder, Pharmacotherapy +4

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β

Bibiana Bielekova, Nancy Richert, T. Howard et al. · Proceedings of the National Academy of Sciences · 2004 · 313 citations · Full text

Neurological Disorder, Immunology, Immune System +17

IFN-β Inhibits Human Th17 Cell Differentiation

Vinod S. Ramgolam, Yonggang Sha, Jianping Jin et al. · The Journal of Immunology · 2009 · 222 citations

T-regulatory Cell, Immunology, Immune Regulation +17

CD4+CD28– costimulation-independent T cells in multiple sclerosis

Silva Markovic‐Plese, Irene Cortese, Klaus‐Peter Wandinger et al. · Journal of Clinical Investigation · 2001 · 217 citations · Full text